首页> 美国卫生研究院文献>International Journal of Ophthalmology >In vitro transdifferentiation of corneal epithelial-like cells from human skin-derived precursor cells
【2h】

In vitro transdifferentiation of corneal epithelial-like cells from human skin-derived precursor cells

机译:角膜上皮样细胞从人皮肤来源的前体细胞的体外转分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The damage of human corneal cells encounter with the problem of availability of corneal cells for replacement. Limitation of the source of corneal cells has been realized. An attempt of development of corneal epithelial-like cells from the human skin-derived precursor (hSKPs) has been made in this study. Combination of three essential growth factors: epidermal growth factor (EGF), keratinocyte growth factor (KGF) and hepatocyte growth factor (HGF) could demonstrate successfully induction of hSKPs to differentiation into corneal cells.The induced cells expressed the appearance of markers of corneal epithelial cells as shown by the presence of keratin 3 (K3) by antibody label and Western blot assay. The K3 gene expression of induced hSKPs cells as shown by reverse transcription-polymerase chain reaction (RT-PCR) technology was also demonstrated. The presence of these markers at both gene and protein levels could lead to our conclusion that the directional transdifferentiation of hSKPs cells into corneal epithelial cells was successfully done under this cell induction protocol. The finding shows a newly available stem cell source can be obtained from easily available skin. Cells from autologous human skin might be used for corneal disorder treatment in future clinical application.
机译:人角膜细胞的损伤遇到了角膜细胞可替代的可用性的问题。已经认识到角膜细胞来源的局限性。在这项研究中,已经尝试从人类皮肤来源的前体(hSKPs)发育角膜上皮样细胞。表皮生长因子(EGF),角质形成细胞生长因子(KGF)和肝细胞生长因子(HGF)这三种基本生长因子的结合可以成功地证明hSKPs诱导分化为角膜细胞。诱导的细胞表达了角膜上皮标记物如通过抗体标记和Western印迹法检测到的角蛋白3(K3)的存在所示。还证明了通过逆转录-聚合酶链反应(RT-PCR)技术显示的诱导的hSKPs细胞的K3基因表达。这些标记物在基因和蛋白质水平上的存在可能导致我们得出的结论是,在此细胞诱导方案下,hSKPs细胞定向转分化为角膜上皮细胞已成功完成。该发现表明可以从容易获得的皮肤中获得新获得的干细胞来源。来自自体人类皮肤的细胞可在未来的临床应用中用于角膜疾病的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号